- Home
- AEHL vs ACXP Comparison
AEHL vs ACXP Comparison
Compare AEHL & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEHL | ACXP |
|---|---|---|
| Founded | 1993 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 6.8M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AEHL | ACXP |
|---|---|---|
| Price | $1.59 | $2.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $143.67 |
| AVG Volume (30 Days) | ★ 2.9M | 60.3K |
| Earning Date | 12-26-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,773,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 36.99 | N/A |
| 52 Week Low | $1.01 | $2.44 |
| 52 Week High | $11.53 | $21.00 |
Technical Indicators
Market Signals| Indicator | AEHL | ACXP |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 39.63 |
| Support Level | $1.51 | $2.44 |
| Resistance Level | $1.85 | $3.54 |
| Average True Range (ATR) | 0.34 | 0.24 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 38.36 | 43.19 |
Price Performance
Historical ComparisonAbout AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.